New Key Statistics Module, Z-Score and F-Score
AMEX:CPHI Key Ratios
| Market Cap $ M | 4.48 |
| Enterprise Value $ M | 7.10 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.63 |
| Price/Sales | 0.51 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 5.00 |
| EPS (TTM) $ | -0.34 |
| Beneish M-Score | -3.57 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.55 |
| EV-to-EBITDA | -4.17 |
| PEG | -- |
| Shares Outstanding M | 19.25 |
| Net Margin (%) | -85.56 |
| Operating Margin % | -82.83 |
| Pre-tax Margin (%) | -85.56 |
| Quick Ratio | 0.26 |
| Current Ratio | 0.79 |
| ROA % (ttm) | -31.32 |
| ROE % (ttm) | -66.27 |
| ROIC % (ttm) | -34.39 |
| Dividend Yield % | -- |
| Altman Z-Score | -4.92 |
CPHI Number of Guru Trades
CPHI Volume of Guru Trades
Gurus Latest Trades with AMEX:CPHI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AMEX:CPHI is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
China Pharma Holding Inc Insider Transactions
No Available Data
News about AMEX:CPHI
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers